XVIPF
Price:
$29.0011
Market Cap:
$8.22B
Xvivo Perfusion AB (publ) is a medical technology company dedicated to advancing transplantation medicine. The firm specializes in pioneering solutions for the preservation and perfusion of organs, tissues, and cells, essential for successful transplant procedures. With a significant international presence, Xvivo Perfusion operates across diverse markets, including Sweden, the United States, wider North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Among its key product offerings is the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass apparatus designed for normothermic ex vivo lung perfusion (EVLP). Complementing this, the company provides th...[Read more]
Industry
Medical - Devices
IPO Date
2014-07-21
Stock Exchange
OTC
Ticker
XVIPF
According to Xvivo Perfusion AB (publ)’s latest financial reports and current stock price. The company's current ROE is 3.49%. This represents a change of 304.11% compared to the average of 0.86% of the last 4 quarters.
The mean historical ROE of Xvivo Perfusion AB (publ) over the last ten years is 1.64%. The current 3.49% ROE has changed 112.75% with respect to the historical average. Over the past ten years (40 quarters), XVIPF's ROE was at its highest in in the September 2024 quarter at 4.12%. The ROE was at its lowest in in the June 2020 quarter at -2.81%.
Average
1.64%
Median
1.22%
Minimum
-4.34%
Maximum
7.98%
Discovering the peaks and valleys of Xvivo Perfusion AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 266.38%
Maximum Annual ROE = 7.98%
Minimum Annual Increase = -607.11%
Minimum Annual ROE = -4.34%
| Year | ROE | Change |
|---|---|---|
| 2025 | 1.19% | -85.09% |
| 2024 | 7.98% | 69.11% |
| 2023 | 4.72% | 266.38% |
| 2022 | 1.29% | 103.17% |
| 2021 | 0.63% | -114.62% |
| 2020 | -4.34% | -607.11% |
| 2019 | 0.86% | -63.56% |
| 2018 | 2.35% | 89.08% |
| 2017 | 1.24% | 161.66% |
| 2016 | 0.47% | -82.91% |
The current ROE of Xvivo Perfusion AB (publ) (XVIPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.63%
5-year avg
3.16%
10-year avg
1.64%
Xvivo Perfusion AB (publ)’s ROE is less than PolyNovo Limited (11.87%), greater than 4DMedical Limited (-890.76%), less than CellaVision AB (publ) (15.43%), less than Lattice Biologics Ltd. (23.33%), less than Swedencare AB (publ) (0.72%), less than Viva Biotech Holdings (5.57%), less than Avon Technologies Plc (10.50%), less than Beijing Tong Ren Tang Chinese Medicine Company Limited (9.74%), greater than Nxera Pharma Co., Ltd. (-15.58%), less than Avisa Diagnostics Inc. (408.59%),
| Company | ROE | Market cap |
|---|---|---|
| 11.87% | $468.81M | |
| -890.76% | $1.59B | |
| 15.43% | $321.76M | |
| 23.33% | $16.55K | |
| 0.72% | $500.30M | |
| 5.57% | $284.79M | |
| 10.50% | $662.29M | |
| 9.74% | $542.78M | |
| -15.58% | $567.36M | |
| 408.59% | $97.18K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xvivo Perfusion AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xvivo Perfusion AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Xvivo Perfusion AB (publ)'s ROE?
How is the ROE calculated for Xvivo Perfusion AB (publ) (XVIPF)?
What is the highest ROE for Xvivo Perfusion AB (publ) (XVIPF)?
What is the 3-year average ROE for Xvivo Perfusion AB (publ) (XVIPF)?
What is the 5-year average ROE for Xvivo Perfusion AB (publ) (XVIPF)?
How does the current ROE for Xvivo Perfusion AB (publ) (XVIPF) compare to its historical average?